跳至主要内容
临床试验/NCT03155516
NCT03155516
Unknown
不适用

Evaluation of the Effect of Good Pain Management (GPM) Ward Program on Pattern of Care and Patient-Reported Outcomes of Moderate to Severe Cancer Pain Patients

Taiwan Mundipharma Pharmaceuticals Ltd.3 个研究点 分布在 1 个国家目标入组 150 人2016年8月30日
适应症CancerPain

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Cancer
发起方
Taiwan Mundipharma Pharmaceuticals Ltd.
入组人数
150
试验地点
3
主要终点
Pain management index (PMI) assessment
最后更新
8年前

概览

简要总结

This study aims to set up a standardized cancer pain ward - known as the Good Pain Management (GPM) Ward with streamlined assessment and management procedures to act as a pain management model. In particular, it will enforce regular pain assessment from and throughout hospital admission, and treatment protocols introducing the use of strong-opioids in moderate cancer pain patients, following National Cancer Care Network (NCCN) Adult Cancer Pain Guidelines. The GPM ward will be compared against current-practice controlled ward.

详细描述

This is a double-arm, randomized, multi-center, current practice-controlled study. Approximately 150 cancer pain patients with collecting questionnaires admitted to an inpatient department from 3 national hospitals: Kaohsiung Medical University Hospital, Kaohsiung Municipal Ta-Tung Hospital and Kaohsiung Municipal HsiaoKang Hospital will be invited into this study. Eligible patients will be randomized to one of the following pain control wards in a 1:1 ratio. * GPM Ward: Good Pain management ward * Control Ward: Current practice-controlled ward Surveys, pain level measurements and dosage used will be collected in 48±8 hours. The pain management index (PMI) will be assessed as primary objective. The patient satisfaction, outcome questionnaire (APS-POQ) and SF-36 will be assessed in secondary objectives. Once patient is admitted to the ward and agrees to participate in the study, the patient will be randomly and blindly assigned to either GPM ward or Control Ward. In the Control Ward, patient will receive the current practice of pain management, with less assessment procedure. This study will investigate the benefits and effect of good pain control on patient outcomes in hospitalized cancer pain patients. The results aim to demonstrate the viability of GPM ward in daily practices and its measurable impact on the patient outcomes including patient treatment satisfaction as well as quality of life. 1. Primary objectives: • To assess pain management index (PMI) 2. Secondary objectives: (1) To assess the satisfaction of pain control during admission (2) To analyze the Patient Outcome Questionnaire (APS-POQ) (3) To analyze the SF-36 Questionnaire

注册库
clinicaltrials.gov
开始日期
2016年8月30日
结束日期
2019年8月29日
最后更新
8年前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

入排标准

入选标准

  • Females and males aged ≥ 20
  • Understand Chinese/Taiwanese and able to finish the questionnaire
  • Alert enough to respond and understand
  • Hospitalized for ≥ 24 hours
  • Cancer patients with cancer-related pain

排除标准

  • Patient diagnosed with non-cancer pain or unexplained pain
  • Patient with moderate to severe mental disorder
  • Patient receiving operation or invasive procedure within 24 hours before admission

结局指标

主要结局

Pain management index (PMI) assessment

时间窗: Up to 56 hours

The change of mean PMI score, pain-reporting rate and adequacy of pain treatment using pain management index

次要结局

  • Satisfaction of pain control during admission(Up to 56 hours)
  • Patient outcome questionnaire (APS-POQ) analysis(Up to 56 hours)
  • SF-36 Questionnaire analysis(Up to 24 hours in screening period)

研究点 (3)

Loading locations...

相似试验